Chirana T. Injecta Group

Chirana T. Injecta Group's price/earnings (P/E) fell 9.89% yoy to 15.4 in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group stock traded at EUR 31.8 per share at the end 2019 translating into a market capitalization of USD 35.7 mil. ...

Chirana T. Injecta Group's net profit rose 11.0% yoy to EUR 2.06 mil in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group made a net profit of EUR 2.06 mil with revenues of EUR 35.9 mil in 2019, up by 11% and up by 6...

Chirana T. Injecta Group's Net Debt/EBITDA fell 8.38% yoy to 1.67 in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group's net debt stood at EUR 11.4 mil and accounted for 33.6% of equity at the end of 2019. The ratio is ...

Profit Statement 2017 2018 2019
Sales EUR mil 33.3 33.8 35.9
Gross Profit EUR mil 14.0 13.7 17.5
EBITDA EUR mil 6.12 6.12 6.80
EBIT EUR mil 2.61 2.43 2.88
Financing Cost EUR mil 0.402 0.193 0.200
Pre-Tax Profit EUR mil 2.24 2.41 2.68
Net Profit EUR mil 1.69 1.86 2.06
Dividends EUR mil ... 0 0
Balance Sheet 2017 2018 2019
Total Assets EUR mil 51.4 52.3 52.8
Non-Current Assets EUR mil 34.7 33.8 33.9
Current Assets EUR mil 16.7 18.4 18.9
Working Capital EUR mil 11.0 11.0 11.7
Shareholders' Equity EUR mil 29.9 31.7 33.8
Liabilities EUR mil 21.5 20.5 19.0
Total Debt EUR mil 14.2 12.3 11.9
Net Debt EUR mil 13.1 11.1 11.4
Ratios 2017 2018 2019
ROE % 5.72 6.04 6.30
ROCE % 3.64 4.10 4.56
Gross Margin % 42.0 40.5 48.9
EBITDA Margin % 18.4 18.1 19.0
EBIT Margin % 7.85 7.18 8.02
Net Margin % 5.07 5.50 5.75
Net Debt/EBITDA 2.14 1.82 1.67
Net Debt/Equity % 43.7 35.2 33.6
Cost of Financing % 2.79 1.46 1.66
Valuation 2017 2018 2019
Market Capitalisation USD mil 38.1 36.4 35.7
Enterprise Value (EV) USD mil 53.8 49.2 48.4
Number Of Shares mil 1.00 1.00 1.00
Share Price EUR 31.8 31.8 31.8
EV/EBITDA 7.83 6.86 6.28
EV/Sales 1.44 1.24 1.19
Price/Earnings (P/E) 18.9 17.1 15.4
Price/Book Value (P/BV) 1.06 1.00 0.942
Dividend Yield % ... 0 0

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
income statement                                    
Sales EUR mil           33.1 33.5 32.3 33.3 33.8               ...
Gross Profit EUR mil           17.6 15.4 12.6 14.0 13.7               ...
EBIT EUR mil           5.61 4.30 1.61 2.61 2.43               ...
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86               ...
                                       
ROE % ...         22.1 14.7 4.02 5.72 6.04               ...
EBIT Margin %           16.9 12.8 4.99 7.85 7.18               ...
Net Margin %           11.0 9.20 3.49 5.07 5.50               ...
balance sheet                                    
Total Assets EUR mil           48.6 53.6 52.5 51.4 52.3               ...
Non-Current Assets EUR mil           28.0 35.3 35.8 34.7 33.8               ...
Current Assets EUR mil           20.6 18.3 16.7 16.7 18.4               ...
                                       
Shareholders' Equity EUR mil           14.9 27.0 29.1 29.9 31.7               ...
Liabilities EUR mil           33.7 26.6 23.4 21.5 20.5               ...
Non-Current Liabilities EUR mil           6.26 15.0 12.4 9.30 6.00               ...
Current Liabilities EUR mil           22.5 11.6 11.9 12.2 14.5               ...
                                       
Net Debt/EBITDA           0.991 2.07 2.72 2.14 1.82               ...
Net Debt/Equity %           57.5 58.7 47.9 43.7 35.2               ...
Cost of Financing % ...         10.2 4.35 2.49 2.79 1.46               ...
cash flow                                    
Total Cash From Operations EUR mil ...         4.65 9.23 3.42 3.75 3.27               ...
Total Cash From Investing EUR mil ...         -4.15 -1.25 -0.844 -1.43 -1.06               ...
Total Cash From Financing EUR mil ...         -1.90 -1.08 -2.82 -1.96 -2.20               ...
Net Change In Cash EUR mil ...         -1.41 6.90 -0.241 0.353 0.009               ...
valuation                                    
Market Capitalisation USD mil ... ... ... ... ... ... ... 33.6 38.1 36.4               ...
Enterprise Value (EV) USD mil ... ... ... ... ... ... ... 48.3 53.8 49.2               ...
Number Of Shares mil ... ... ... ... ... ... ... 1.00 1.00 1.00               ...
Share Price EUR ... ... ... ... ... ... ... 31.8 31.8 31.8               ...
Price/Earnings (P/E) ... ... ... ... ... ... ... 28.2 18.9 17.1               ...
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... 6.84 6.12 5.73               ...
EV/EBITDA ... ... ... ... ... ... ... 8.78 7.83 6.86               ...
Price/Book Value (P/BV) ... ... ... ... ... ... ... 1.09 1.06 1.00               ...
Dividend Yield % ... ... ... ... ... ... ... ... ... 0               ...
income statement Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
income statement                                    
Sales EUR mil           33.1 33.5 32.3 33.3 33.8               ...
Cost of Goods & Services EUR mil           15.6 18.1 19.6 19.3 20.1               ...
Gross Profit EUR mil           17.6 15.4 12.6 14.0 13.7               ...
Staff Cost EUR mil           6.30 7.73 7.85 8.68 9.61               ...
Other Operating Cost (Income) EUR mil           2.64 0 -0.345 -0.838 -2.04               ...
EBITDA EUR mil           8.63 7.67 5.14 6.12 6.12               ...
Depreciation EUR mil           3.03 3.36 3.52 3.51 3.69               ...
EBIT EUR mil           5.61 4.30 1.61 2.61 2.43               ...
Net Financing Cost EUR mil           0.912 0.583 0.392 0.402 0.193               ...
Financing Cost EUR mil           0.912 0.583 0.392 0.402 0.193               ...
Extraordinary Cost EUR mil           0 -0.370 -0.258 -0.033 -0.178               ...
Pre-Tax Profit EUR mil           4.69 4.09 1.48 2.24 2.41               ...
Tax EUR mil           1.04 1.01 0.351 0.557 0.553               ...
Minorities EUR mil           0 0 0 0 0               ...
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86               ...
Net Profit Avail. to Common EUR mil           3.65 3.08 1.13 1.69 1.86               ...
Dividends EUR mil ... ... ... ... ... ... ... ... ... 0               ...
growth rates                                    
Total Revenue Growth % ...         11.0 1.07 -3.60 3.07 1.65               ...
Staff Cost Growth % ...         7.67 22.8 1.47 10.6 10.7               ...
EBITDA Growth % ...         -10.1 -11.2 -33.0 19.2 0               ...
EBIT Growth % ...         -18.5 -23.3 -62.5 0 ...               ...
Pre-Tax Profit Growth % ...         -31.4 -12.9 -63.9 51.8 7.49               ...
Net Profit Growth % ...         -32.3 -15.6 -63.4 49.7 10.2               ...
ratios                                    
ROE % ...         22.1 14.7 4.02 5.72 6.04               ...
ROA % ...         8.61 6.03 2.12 3.25 3.59               ...
ROCE % ...         12.1 7.84 2.38 3.64 4.10               ...
Gross Margin %           53.0 46.0 39.2 42.0 40.5               ...
EBITDA Margin %           26.1 22.9 15.9 18.4 18.1               ...
EBIT Margin %           16.9 12.8 4.99 7.85 7.18               ...
Net Margin %           11.0 9.20 3.49 5.07 5.50               ...
Payout Ratio % ... ... ... ... ... ... ... ... ... 0               ...
Cost of Financing % ...         10.2 4.35 2.49 2.79 1.46               ...
Net Debt/EBITDA           0.991 2.07 2.72 2.14 1.82               ...
balance sheet Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
balance sheet                                    
Cash & Cash Equivalents EUR mil           1.41 0.984 0.743 1.10 1.11               ...
Receivables EUR mil           12.2 9.37 6.69 7.23 7.32               ...
Inventories EUR mil           6.87 7.91 9.27 8.38 10.0               ...
Other ST Assets EUR mil           0.060 0 < 0.001 < -0.001 < -0.001               ...
Current Assets EUR mil           20.6 18.3 16.7 16.7 18.4               ...
Property, Plant & Equipment EUR mil           19.9 19.1 17.5 15.3 13.0               ...
LT Investments & Receivables EUR mil           8.15 1.32 3.44 4.38 5.80               ...
Intangible Assets EUR mil           0 14.9 14.9 15.0 15.0               ...
Goodwill EUR mil           0 14.8 14.8 14.8 14.8               ...
Non-Current Assets EUR mil           28.0 35.3 35.8 34.7 33.8               ...
Total Assets EUR mil           48.6 53.6 52.5 51.4 52.3               ...
                                       
Trade Payables EUR mil           16.4 4.69 4.84 4.64 6.27               ...
Short-Term Debt EUR mil           5.37 6.32 6.37 6.84 7.52               ...
Other ST Liabilities EUR mil           0.719 0.628 0.743 0.756 0.742               ...
Current Liabilities EUR mil           22.5 11.6 11.9 12.2 14.5               ...
Long-Term Debt EUR mil           4.60 10.5 8.33 7.32 4.73               ...
Other LT Liabilities EUR mil           1.67 4.47 4.10 1.98 1.27               ...
Non-Current Liabilities EUR mil           6.26 15.0 12.4 9.30 6.00               ...
Liabilities EUR mil           33.7 26.6 23.4 21.5 20.5               ...
Equity Before Minority Interest EUR mil           14.9 27.0 29.1 29.9 31.7               ...
Minority Interest EUR mil           0 0 0 0 0               ...
Equity EUR mil           14.9 27.0 29.1 29.9 31.7               ...
growth rates                                    
Total Asset Growth % ...         34.0 10.3 -2.07 -2.00 1.59               ...
Shareholders' Equity Growth % ...         -18.4 81.4 7.87 2.70 6.07               ...
Net Debt Growth % ...         65.1 85.2 -11.9 -6.32 -14.7               ...
Total Debt Growth % ...         24.6 68.8 -12.6 -3.60 -13.5               ...
ratios                                    
Total Debt EUR mil           9.96 16.8 14.7 14.2 12.3               ...
Net Debt EUR mil           8.55 15.8 14.0 13.1 11.1               ...
Working Capital EUR mil           2.70 12.6 11.1 11.0 11.0               ...
Capital Employed EUR mil           30.7 47.9 46.9 45.7 44.9               ...
Net Debt/Equity %           57.5 58.7 47.9 43.7 35.2               ...
Current Ratio           0.915 1.57 1.40 1.37 1.27               ...
Quick Ratio           0.607 0.890 0.622 0.681 0.579               ...
cash flow Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
cash flow                                    
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86               ...
Depreciation EUR mil           3.03 3.36 3.52 3.51 3.69               ...
Non-Cash Items EUR mil ...         -9.83 12.7 -2.69 -1.60 -2.21               ...
Change in Working Capital EUR mil ...         7.80 -9.88 1.46 0.156 -0.077               ...
Total Cash From Operations EUR mil ...         4.65 9.23 3.42 3.75 3.27               ...
                                       
Capital Expenditures EUR mil ...         -4.15 -1.35 -1.03 -1.87 -1.45               ...
Other Investing Activities EUR mil ...         0 0.102 0.190 0.432 0.391               ...
Total Cash From Investing EUR mil ...         -4.15 -1.25 -0.844 -1.43 -1.06               ...
                                       
Dividends Paid EUR mil ... ... ... ... ... ... ... ... ... ...                
Issuance Of Debt EUR mil ...         1.97 6.86 -2.13 -0.529 -1.91               ...
Total Cash From Financing EUR mil ...         -1.90 -1.08 -2.82 -1.96 -2.20               ...
Net Change In Cash EUR mil ...         -1.41 6.90 -0.241 0.353 0.009               ...
ratios                                    
Days Sales Outstanding days           135 102 75.7 79.4 79.0               ...
Days Sales Of Inventory days           161 160 172 158 181               ...
Days Payable Outstanding days           385 94.7 89.9 87.7 114               ...
Cash Conversion Cycle days           -88.8 167 158 150 147               ...
Cash Earnings EUR mil           6.68 6.45 4.65 5.20 5.55               ...
Free Cash Flow EUR mil ...         0.497 7.98 2.58 2.32 2.21               ...
Capital Expenditures (As % of Sales) % ...         12.5 4.02 3.20 5.61 4.28               ...
other ratios Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
                                     
Staff Cost (As % of Sales) %           19.0 23.1 24.3 26.1 28.4               ...
Effective Tax Rate %           22.2 24.6 23.7 24.8 22.9               ...
Total Revenue Growth (5-year average) % ... ... ... ... ... 11.6 10.1 2.50 2.40 2.54               ...
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ...               ...
valuation Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
                                     
Market Capitalisation USD mil ... ... ... ... ... ... ... 33.6 38.1 36.4               ...
Enterprise Value (EV) USD mil ... ... ... ... ... ... ... 48.3 53.8 49.2               ...
Number Of Shares mil ... ... ... ... ... ... ... 1.00 1.00 1.00               ...
Share Price EUR ... ... ... ... ... ... ... 31.8 31.8 31.8               ...
EV/EBITDA ... ... ... ... ... ... ... 8.78 7.83 6.86               ...
Price/Earnings (P/E) ... ... ... ... ... ... ... 28.2 18.9 17.1               ...
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... 6.84 6.12 5.73               ...
P/FCF ... ... ... ... ... ... ... 12.3 13.7 14.4               ...
Price/Book Value (P/BV) ... ... ... ... ... ... ... 1.09 1.06 1.00               ...
Dividend Yield % ... ... ... ... ... ... ... ... ... 0               ...
Free Cash Flow Yield % ... ... ... ... ... ... ... 8.23 6.82 7.12               ...
Earnings Per Share (EPS) EUR ... ... ... ... ... ... ... 1.13 1.69 1.86               ...
Cash Earnings Per Share EUR ... ... ... ... ... ... ... 4.65 5.20 5.55               ...
Free Cash Flow Per Share EUR ... ... ... ... ... ... ... 2.58 2.32 2.21               ...
Book Value Per Share EUR ... ... ... ... ... ... ... 29.1 29.9 31.7               ...
Dividend Per Share EUR ... ... ... ... ... ... ... ... ... 0               ...
EV/Sales ... ... ... ... ... ... ... 1.40 1.44 1.24               ...
EV/EBIT ... ... ... ... ... ... ... 28.0 18.3 17.3               ...
EV/Free Cash Flow ... ... ... ... ... ... ... 17.5 20.7 19.0               ...
EV/Capital Employed ... ... ... ... ... ... ... 0.976 0.982 0.957               ...
Earnings Per Share Growth % ... ... ... ... ... ... ... ... 49.7 10.2               ...
Cash Earnings Per Share Growth % ... ... ... ... ... ... ... ... 11.7 6.89               ...
Book Value Per Share Growth % ... ... ... ... ... ... ... ... 2.70 6.07               ...

Get all company financials in excel:

Download Sample   $19.99

Chirana T. Injecta Group's Share Price remain unchanged yoy at EUR 31.8 in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group stock traded at EUR 31.8 per share at the end 2019 implying a market capitalization of USD 35.7 mil. Since the end of 2014, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company ...

Chirana T. Injecta Group's Net Margin rose 4.57% yoy to 5.75% in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group made a net profit of EUR 2.06 mil with revenues of EUR 35.9 mil in 2019, up by 11.0% and up by 6.13%, respectively, compared to the previous year. This translates into a net margin of 5.75%. Historically, between 2009 and 2019, ...

Chirana T. Injecta Group's Capital Expenditures fell 176% yoy to EUR 4.00 mil in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group invested a total of EUR 4.00 mil in 2019, up 176% compared to the previous year. Historically, between 2010 - 2019, the company's investments stood at a high of EUR 4.15 mil in 2014 and a low of EUR 0.088 mil in 2010...

Chirana T. Injecta Group's P/FCF fell 421% yoy to -46.1 in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group stock traded at EUR 31.8 per share at the end 2019 translating into a market capitalization of USD 35.7 mil. Since the end of 2014, the stock has appreciated by 0% representing an annual average growth of %. At the end of 2019, t...

Chirana T. Injecta Group's ROCE rose 11.1% yoy to 4.56% in 2019

By Helgi Analytics - December 1, 2020

Chirana T. Injecta Group made a net profit of EUR 2.06 mil in 2019, up 11% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of EUR 6.09 mil in 2012 and a low of EUR 1.13 mil in 2016. The result im...

More News

Finance

Chirana T. Injecta Group has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 100% a year during that time to total of in 2026, or of sales. That’s compared to 17.3% average margin seen in last five years.

The company netted in 2026 implying ROE of and ROCE of . Again, the average figures were 6.30% and 5.86%, respectively when looking at the previous 5 years.

Chirana T. Injecta Group’s net debt amounted to at the end of 2026, or of equity. When compared to EBITDA, net debt was x,

A PHP Error was encountered

Severity: Warning

Message: A non-numeric value encountered

Filename: src/Environment.php(418) : eval()'d code

Line Number: 345

down when compared to average of 1.16x seen in the last 5 years.

Valuation

Chirana T. Injecta Group stock traded at per share at the end of 2026 resulting in a market capitalization of . Over the previous five years, stock price fell by 0% or -100% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2026.

More Companies in Slovak Pharmaceutical Sector